Committee Hearings, Extending the Patent Term for Drugs Undergoing
FDA Review During the Enactment of Hatch-Waxman
This page contains testimony given before Congressional committees related
to this issue. Note that many organizations giving testimony before committees
also have statements and information available on their own webpages. That material
is available under organizational statements.
This page contains all abstracts from hearings, but only selected transcripts
released electronically by the relevant committee.
Abstracts:
Testimony:
-
Rep. Michael Bilirakis, et al., House Commerce Committee, Health and Environment
Subcommittee, 9/13/00
- Stephen
W. Gammarino - Blue Cross and Blue Shield Association, House Government Reform
Committee, Civil Service Subcommittee, 6/13/00
- Robert
Pitofsky - Federal Trade Commission, House Judiciary Committee, 4/12/00
- Andrew
M. Berdon - Coalition for Affordable Pharmaceuticals, et al., House Judiciary
Committee, Courts and Intellectual Property Subcommittee, 7/1/99
- Rep.
Marion Berry, House Judiciary Committee, Courts and Intellectual Property
Subcommittee, 7/1/99
- Gordon
M. Binder - Amgen, House Judiciary Committee, Courts and Intellectual Property
Subcommittee, 7/1/99
- Rep.
Ed Bryant, House Judiciary Committee, Courts and Intellectual Property Subcommittee,
7/1/99
- Rep.
Howard Coble, House Judiciary Committee, Courts and Intellectual Property
Subcommittee, 7/1/99
- Bruce
L. Downey - Barr Laboratories, Inc, House Judiciary Committee, Courts and
Intellectual Property Subcommittee, 7/1/99
- Peter
Barton Hutt, House Judiciary Committee, Courts and Intellectual Property Subcommittee,
7/1/99
- Maura
Kealey - Public Citizen, House Judiciary Committee, Courts and Intellectual
Property Subcommittee, 7/1/99
- Bruce
A. Lehman, House Judiciary Committee, Courts and Intellectual Property Subcommittee,
7/1/99
- Rep.
Jim McDermott, House Judiciary Committee, Courts and Intellectual Property
Subcommittee, 7/1/99
- Richard
F Selden - Transkaryotic Therapies, Inc., House Judiciary Committee, Courts
and Intellectual Property Subcommittee, 7/1/99
- Jonathan
Spicehandler - Schering-Plough Corporation, House Judiciary Committee, Courts
and Intellectual Property Subcommittee, 7/1/99
- Sen.
Robert G. Toricelli, House Judiciary Committee, Courts and Intellectual Property
Subcommittee, 7/1/99
- Rep.
Henry A. Waxman, et al., House Judiciary Committee, Courts and Intellectual
Property Subcommittee, 7/1/99
- Marjorie
Dorr - Blue Cross and Blue Shield Association, Senate Finance Committee, 3/29/00
- Sen.
Byron L. Dorgan, Senate Health, Education, Labor, and Pensions Committee,
6/13/00
- John
D. Golenski - RxHealthValue, Senate Health, Education, Labor, and Pensions
Committee, 7/18/00
- Rep.
Ed Bryant, Senate Judiciary Committee, 8/4/99
- Bruce
L. Downey - Barr Laboratories, Inc., Senate Judiciary Committee, 8/4/99
- Carole
S. Goldfine Ben-Maimon - Generic Pharmaceutical Industry Association, Senate
Judiciary Committee, 8/4/99
- Sen.
Orrin Hatch, Senate Judiciary Committee, 8/4/99
- Peter
Barton Hutt, Senate Judiciary Committee, 8/4/99
- Sen.
Edward M. Kennedy, Senate Judiciary Committee, 8/4/99
- Richard
Jay Kogan - Schering-Plough Corporation, Senate Judiciary Committee, 8/4/99
- Sen.
Patrick Leahy, Senate Judiciary Committee, 8/4/99
- Rep.
Jim McDermott, Senate Judiciary Committee, 8/4/99
- Howard
M. Metzenbaum - Consumer Federation of America, Senate Judiciary Committee,
8/4/99
- Robert
Pitofsky - Federal Trade Commission, Senate Judiciary Committee, Antitrust,
Business Rights and Competition Subcommittee, 3/22/00